Who’s making millions from the sale of the abortion pill? The answer may surprise you.
Live Action News has uncovered a document which indicates that the Population Council, a non-profit founded by eugenicists (which brought the abortion pill to the U.S. and then created manufacturer DANCO Laboratories to market the drug known as mifepristone) was originally set up to receive royalties from sales of the abortion pill.
The information was found within the organization’s 1998 990 and is seen in the image below. A review of Population Council annual reports reveal that, despite the group’s creation of an abortion pill company, millions of taxpayer dollars have been funneled to the Population Council since the late 1990’s.
Live Action News previously documented:
1993 – President Bill Clinton signed an executive order directing the FDA to expedite marketing of the abortion pill.
1994 – With encouragement of the Clinton administration, French manufacturer Roussel-Uclaf assigned U.S. rights of marketing and distribution of RU-486 over to the Population Council.
The right to distribute the abortion pill was later handed over to DANCO Laboratories, a sub-licensee of the Population Council.
1996 – The David and Lucile Packard Foundation seeded DANCO with $14.2 million. Packard would go on to fund Gynuity Health Projects, which is currently conducting abortion pill clinical trials as well as a number of studies, to expand the drug further.
substantial amount of the Population Council’s current and past funding appears to be from the U.S. government as well as royalty revenue. Royalty revenue was rarely defined in all the reports Live Action News reviewed (linked below) so it is impossible to know if the Population Council is still receiving royalty dollars from the abortion pill. “Royalty” could mean multiple things and could even include payments made for investments — or as one Population Council document describes it, “gifts of oil, gas, and mineral interests.'” However, it could also be as another Population Control document defines it: “generated from the licensing of Council-developed products,” such as the royalty deal they brokered over mifepristone, detailed in the 2002 990 (image below).
While it is unclear whether the Population Council continues to profit from the abortion pill via a royalty payment, it is undeniable that U.S. taxpayers are subsidizing their work. A review of the organization’s annual reports reveal the following:
By Carole Novielli | December 30, 2019 , 02:55pm